BNP PARIBAS FINANCIAL MARKETS - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$25,315
-43.4%
14,718
-35.8%
0.00%
Q2 2023$44,735
+2437.4%
22,941
+3518.5%
0.00%
Q1 2023$1,763
-56.4%
634
-46.0%
0.00%
Q4 2022$4,047
-100.0%
1,173
-80.8%
0.00%
Q3 2022$15,736,000
+89.0%
6,123
+78.0%
0.00%
Q2 2022$8,325,000
-63.6%
3,440
-38.0%
0.00%
Q1 2022$22,870,000
-89.5%
5,551
-67.3%
0.00%
Q4 2021$218,581,000
+123.1%
16,997
+87.4%
0.00%
Q3 2021$97,967,000
+88.2%
9,071
+59.1%
0.00%
Q2 2021$52,050,000
-49.9%
5,701
-48.3%
0.00%
Q1 2021$103,890,000
+325.8%
11,017
+77.9%
0.00%
Q4 2020$24,396,000
+26.4%
6,192
-15.0%
0.00%
Q3 2020$19,300,000
+98.9%
7,283
+398.5%
0.00%
Q2 2020$9,701,000
-78.4%
1,461
-81.0%
0.00%
Q1 2020$44,849,000
+71.9%
7,706
+165.0%
0.00%
Q4 2019$26,085,000
-11.6%
2,908
-14.9%
0.00%
Q3 2019$29,497,000
+51.3%
3,416
+95.2%
0.00%
Q2 2019$19,495,000
-10.7%
1,750
+6.6%
0.00%
Q1 2019$21,839,0001,6420.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders